Literature DB >> 14513059

BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis.

B Schultheis, L Wang, R E Clark, J V Melo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14513059     DOI： 10.1038/sj.leu.2403079

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210BCR-ABL1 and P195BCR-ABL1 isoforms.

Authors:  Raquel Vinhas; Alexandra Lourenço; Susana Santos; Patrícia Ribeiro; Madalena Silva; Aida Botelho de Sousa; Pedro V Baptista; Alexandra R Fernandes
Journal:  Haematologica       Date:  2018-08-09       Impact factor: 9.941

2.  BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.

Authors:  Antonella Zagaria; Luisa Anelli; Nicoletta Coccaro; Giuseppina Tota; Paola Casieri; Angelo Cellamare; Luciana Impera; Claudia Brunetti; Angela Minervini; Crescenzio Francesco Minervini; Mario Delia; Cosimo Cumbo; Paola Orsini; Giorgina Specchia; Francesco Albano
Journal:  Virchows Arch       Date:  2015-07-07       Impact factor: 4.064

3.  Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript.

Authors:  Sang-Yong Shin; Jin-Hee Cho; Hee-Jin Kim; Jun-Ho Jang; Seung-Tae Lee; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

4.  A case of acute myeloid leukemia with e6a2 BCR-ABL fusion transcript acquired after progressing from chronic myelomonocytic leukemia.

Authors:  Jinjuan Yao; Dan Douer; Lu Wang; Maria E Arcila; Khedoudja Nafa; April Chiu
Journal:  Leuk Res Rep       Date:  2017-01-31

5.  Chronic Myeloid Leukemia with an e6a2 BCR-ABL1 Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring.

Authors:  Mireille Crampe; Karl Haslam; Emma Groarke; Eileen Kelleher; Derville O'Shea; Eibhlin Conneally; Stephen E Langabeer
Journal:  Case Rep Hematol       Date:  2017-10-16

6.  Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis.

Authors:  Marte Karen Brattås; Kyrre Lilleeng; Randi Hovland; Ingvild Jenssen Lægreid; Marta Vorland; Friedemann Leh; Øystein Bruserud; Bjørn Tore Gjertsen; Håkon Reikvam
Journal:  Biomark Res       Date:  2018-11-21

Review 7.  HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?

Authors:  Hélène Losson; Michael Schnekenburger; Mario Dicato; Marc Diederich
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

8.  Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report.

Authors:  Livia Manzella; Elena Tirrò; Silvia Rita Vitale; Adriana Puma; Maria Letizia Consoli; Loredana Tambè; Maria Stella Pennisi; Sandra DI Gregorio; Chiara Romano; Cristina Tomarchio; Francesco DI Raimondo; Fabio Stagno
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 9.  Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: A case report and literature review.

Authors:  Yasuhiko Harada; Satoshi Nishiwaki; Takumi Sugimoto; Koichi Onodera; Tatsunori Goto; Takahiko Sato; Sonoko Kamoshita; Naomi Kawashima; Aika Seto; Shingo Okuno; Satomi Yamamoto; Toshihiro Iwasaki; Yukiyasu Ozawa; Koichi Miyamura; Yoshiki Akatsuka; Isamu Sugiura
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 10.  Prognostic Significance of Transcript-Type BCR - ABL1 in Chronic Myeloid Leukemia.

Authors:  Matteo Molica; Elisabetta Abruzzese; Massimo Breccia
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.